Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05571800 · ClinicalTrials.gov registry record · NA
Effect of Mango Consumption on Individuals with Pre-diabetes
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT05571800: Completed NA study, sponsored by Florida State University.
NCT05571800 is a NA study that has completed, run by Florida State University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05571800, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study is designed to explore the effect of mango consumption on glycemic indices, cardiovascular health, and body composition in overweight and obese individuals with prediabetes.
Primary Outcome
Blood glucose measures evaluated with finger prick and blood glucose meter
Interventions
- OTHER Placebo
- OTHER Mango
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
What the finished NCT05571800 record still lists
NCT05571800 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05571800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05571800 about?
NCT05571800 is a clinical study titled "Effect of Mango Consumption on Individuals with Pre-diabetes". This study is designed to explore the effect of mango consumption on glycemic indices, cardiovascular health, and body composition in overweight and obese individuals with prediabetes.
What is the current status of trial NCT05571800?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2022-05-01. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT05571800?
The interventions under investigation include: Placebo (OTHER), Mango (OTHER).
Who is sponsoring clinical trial NCT05571800?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05571800's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI